Pfizer Laboratories Div Pfizer Inc drugs

56 results

  • Abrilada (adalimumab-afzb)

    (adalimumab-afzb)
    Pfizer Laboratories Div Pfizer Inc
    Usage: ABRILADA is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients 2 years and older.

  • Abrysvo

    (Respiratory Syncytial Virus Vaccine)
    Pfizer Laboratories Div Pfizer Inc
    Usage: ABRYSVO is a vaccine indicated for active immunization against lower respiratory tract disease (LRTD) caused by RSV. It is for pregnant individuals (32-36 weeks gestation), individuals 60 years and older, and adults 18-59 years at increased risk for RSV-related LRTD.

  • Aldactazide (spironolactone and hydrochlorothiazide)

    (spironolactone and hydrochlorothiazide)
    Pfizer Laboratories Div Pfizer Inc
    Usage: ALDACTAZIDE is indicated for managing edematous conditions in congestive heart failure, cirrhosis with edema, nephrotic syndrome, and for treating essential hypertension. It is also used for diuretic-induced hypokalemia when other therapies are inadequate. Routine diuretic use during pregnancy is inappropriate unless due to pathological causes.

  • Beqvez (fidanacogene elaparvovec-dzkt)

    (fidanacogene elaparvovec-dzkt)
    Pfizer Laboratories Div Pfizer Inc
    Usage: BEQVEZ is a gene therapy for adults with moderate to severe hemophilia B, indicated for those on factor IX prophylaxis, experiencing life-threatening hemorrhages or serious spontaneous bleeding, and without neutralizing antibodies to AAVRh74var capsid, based on FDA-approved diagnostics.

  • Bosulif

    (Bosutinib)
    Pfizer Laboratories Div Pfizer Inc
    Usage: BOSULIF is indicated for treating chronic phase Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) in adults and pediatric patients (1 year and older), as well as for adult patients with accelerated or blast phase Ph+ CML who have resistance or intolerance to prior therapy.

  • Caduet

    (amlodipine besylate and atorvastatin calcium)
    Pfizer Laboratories Div Pfizer Inc
    Usage: CADUET (amlodipine and atorvastatin) is indicated for patients requiring both hypertension management and lipid control. Amlodipine treats high blood pressure and various types of angina, while atorvastatin reduces risk of cardiovascular events and lowers LDL cholesterol in hyperlipidemia.

  • Celebrex

    (Celecoxib)
    PFIZER LABORATORIES DIV PFIZER INC
    Usage: CELEBREX is indicated for managing signs and symptoms of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis (in patients aged 2 and older), ankylosing spondylitis, acute pain in adults, and primary dysmenorrhea.

  • Cibinqo (abrocitinib)

    (abrocitinib)
    Pfizer Laboratories Div Pfizer Inc
    Usage: CIBINQO is indicated for treating adults and pediatric patients aged 12 and older with refractory, moderate-to-severe atopic dermatitis not adequately controlled by other systemic treatments, including biologics, or when those therapies are inadvisable. It is not recommended for use with other JAK inhibitors or immunosuppressants.

  • Comirnaty

    (COVID-19 Vaccine, mRNA)
    Pfizer Laboratories Div Pfizer Inc
    Usage: COMIRNATY is a vaccine indicated for active immunization against coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 in individuals aged 12 years and older.

  • Cutaquig

    (immunoglobulin G)
    Pfizer Laboratories Div Pfizer Inc
    Usage: CUTAQUIG is indicated for replacement therapy in primary humoral immunodeficiency in adults and children aged 2 and older. Conditions include common variable immunodeficiency, X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.